<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1047100852003296&ev=PageView&noscript=1" />

Akesion - One Solution

Thumbnail of Akesion - One Solution

Of patients who undergo abdominal surgery, over 50% develop adverse adhesions between organs. Adhesions often lead to pain, infertility and, in severe cases, to life-threatening bowel obstruction. A new drug developed by the startup company Akesion removes the main precursor of these adhesions preventing the formation of adhesions as well as risky repeat surgeries that are stressful to patients.


Video insights

CODE

Language

VIEWS

SLICE

deu
German

105

68.2%

eng
English

43

27.9%

spa
Spanish

3

1.9%

fra
French

3

1.9%

total

154

100%

Report This Video

Thank you for helping us with your report! Please state the error you found within the video and we'll check out what's bugging you.

Wrong language played

Video was out of synch

Illegal content

Bad translation

Poor audio quality

No Sound in selected Language

"I comply with alugha's privacy policy"